|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:FOS-LGALS3BP (FusionGDB2 ID:31035) |
Fusion Gene Summary for FOS-LGALS3BP |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FOS-LGALS3BP | Fusion gene ID: 31035 | Hgene | Tgene | Gene symbol | FOS | LGALS3BP | Gene ID | 2353 | 3959 |
| Gene name | Fos proto-oncogene, AP-1 transcription factor subunit | galectin 3 binding protein | |
| Synonyms | AP-1|C-FOS|p55 | 90K|BTBD17B|CyCAP|M2BP|MAC-2-BP|TANGO10B|gp90 | |
| Cytomap | 14q24.3 | 17q25.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | proto-oncogene c-FosFBJ murine osteosarcoma viral (v-fos) oncogene homolog (oncogene FOS)FBJ murine osteosarcoma viral oncogene homologFos proto-oncogene, AP-1 trancription factor subunitG0/G1 switch regulatory protein 7activator protein 1cellular o | galectin-3-binding proteinL3 antigenMAC2BPMac-2-binding proteinbasement membrane autoantigen p105lectin galactoside-binding soluble 3-binding proteinmac-2 BPserum protein 90Ktransport and golgi organization 10 homolog Btumor-associated antigen 90 | |
| Modification date | 20200329 | 20200322 | |
| UniProtAcc | P01100 | Q08380 | |
| Ensembl transtripts involved in fusion gene | ENST00000556324, ENST00000303562, ENST00000535987, ENST00000554617, ENST00000555242, ENST00000555347, ENST00000555686, | ENST00000262776, ENST00000585407, ENST00000591778, | |
| Fusion gene scores | * DoF score | 6 X 9 X 1=54 | 11 X 12 X 6=792 |
| # samples | 9 | 13 | |
| ** MAII score | log2(9/54*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(13/792*10)=-2.60698880705116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: FOS [Title/Abstract] AND LGALS3BP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | FOS(75745631)-LGALS3BP(76969713), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | FOS | GO:0007179 | transforming growth factor beta receptor signaling pathway | 9732876 |
| Hgene | FOS | GO:0034614 | cellular response to reactive oxygen species | 17217916 |
| Hgene | FOS | GO:0045893 | positive regulation of transcription, DNA-templated | 9732876 |
| Hgene | FOS | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10508860 |
| Hgene | FOS | GO:0060395 | SMAD protein signal transduction | 9732876 |
| Fusion gene breakpoints across FOS (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across LGALS3BP (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | DB255923 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
Top |
Fusion Gene ORF analysis for FOS-LGALS3BP |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-intron | ENST00000556324 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 3UTR-intron | ENST00000556324 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 3UTR-intron | ENST00000556324 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000303562 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000303562 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000303562 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000535987 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000535987 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000535987 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000554617 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000554617 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| 5UTR-intron | ENST00000554617 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555242 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555242 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555242 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555347 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555347 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555347 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555686 | ENST00000262776 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555686 | ENST00000585407 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| intron-intron | ENST00000555686 | ENST00000591778 | FOS | chr14 | 75745631 | + | LGALS3BP | chr17 | 76969713 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for FOS-LGALS3BP |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FOS-LGALS3BP |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:75745631/:76969713) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FOS | LGALS3BP |
| FUNCTION: Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation. In growing cells, activates phospholipid synthesis, possibly by activating CDS1 and PI4K2A. This activity requires Tyr-dephosphorylation and association with the endoplasmic reticulum. {ECO:0000269|PubMed:16055710, ECO:0000269|PubMed:17160021, ECO:0000269|PubMed:22105363, ECO:0000269|PubMed:7588633, ECO:0000269|PubMed:9732876}. | FUNCTION: Promotes integrin-mediated cell adhesion. May stimulate host defense against viruses and tumor cells. {ECO:0000269|PubMed:11146440, ECO:0000269|PubMed:8034587, ECO:0000269|PubMed:9501082}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for FOS-LGALS3BP |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for FOS-LGALS3BP |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FOS-LGALS3BP |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FOS-LGALS3BP |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies